PERILYTE
Natural health product licensed in Canada
- Licence holder
- HTLTSupps
- NPN or DIN-HM
- 80127724
- Status
- Active licence
- Licence date
- 1 November 2023
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Thréonine Source : L-thréonine | 750 mg | Not calculated |
| Potassium Source : Citrate de potassium | 200 mg | Not calculated |
| L-Tryptophane Source : L-Tryptophane | 22 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 100 mg | Not calculated |
| L-Lysine Source : L-Lysine | 750 mg | Not calculated |
| Riboflavine Source : Riboflavine | 250 Microgrammes | Not calculated |
| L-Isoleucine Source : L-isoleucine | 1,250 mg | Not calculated |
| L-Valine Source : L-valine | 1,250 mg | Not calculated |
Non-medicinal ingredients
Rouge FD&C N° 40, Saveur, Sucralose, Laque d'aluminium bleu FD&C n° 1, Dioxyde de silicium, Bicarbonate de sodium, Chlorure de sodium, Poudre de jus de betterave, Acide L-malique, Acésulfame potassium, Laque d'aluminium jaune FD&C No. 5, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of (an) (essential) amino acid(s) involved in muscle protein synthesis. Source of branched chain amino acids (BCAAs), which are involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80127724
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.